An Economic Model of Stroke in Atrial Fibrillation: The Cost of Suboptimal Oral AnticoagulationByJ. Jaime Caro, MDCM, FRCPCDecember 1st 2004
Stroke Prevention in Atrial Fibrillation: Pooled Analysis of SPORTIF III and V TrialsByGregory W. Albers*, MD, on behalf of the SPORTIF InvestigatorsDecember 1st 2004
